Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Working Capital Ratio & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Working Capital Ratio

LCTX Working Capital Ratio

Latest reported42.45%period endingDec 31, 2025

LCTX FY Working Capital Ratio (95.83% → 42.45%)

Annual working capital ratio

High-resolution chart · PNG

LCTX working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Working Capital Ratio — Annual fiscal periods
Period ending	Working Capital Ratio
Dec 31, 2025	42.4483%
Dec 31, 2024	32.698%
Dec 31, 2023	20.2744%
Dec 31, 2022	33.1697%
Dec 31, 2021	36.9148%
Dec 31, 2020	33.5621%
Dec 31, 2019	40.6645%
Dec 31, 2018	29.0635%
Dec 31, 2017	20.6325%
Dec 31, 2016	11.7828%
Dec 31, 2015	36.7367%
Dec 31, 2014	33.745%
Dec 31, 2013	1.7185%
Dec 31, 2012	9.374%
Dec 31, 2011	47.5864%
Dec 31, 2010	62.1195%
Dec 31, 2009	83.4043%
Dec 31, 2008	-315.7681%
Dec 31, 2007	-751.7653%
Dec 31, 2006	0.4679%
Dec 31, 2005	62.5405%
Dec 31, 2004	80.0302%
Dec 31, 2003	-194.7873%
Dec 31, 2002	59.0673%
Dec 31, 2001	74.8352%
Dec 31, 2000	64.4559%
Dec 31, 1999	84.6079%
Dec 31, 1998	78.5714%
Jun 30, 1998	86.5672%
Jun 30, 1996	93.3333%
Jun 30, 1995	88.8889%
Jun 30, 1994	98.3051%
Jun 30, 1993	100%
Jun 30, 1992	95.8333%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.